Incorporating Biometric Data for Patients Receiving Concurrent Chemotherapy & RT
Part of paid clinical trials in Wilmington, North Carolina.
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Study ID
- NCT05937659
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
This study will assess the feasibility of incorporating biometric data via wearable health technology (WHT) into the radiation oncology (RO) clinic workflow for patients receiving concurrent radiation therapy and systemic therapy (CRT) for cancer. The investigators hypothesize that a practical workflow could be created within a busy community RO practice that will allow providers and patients to readily appreciate physiologic declines during concurrent CRT. Subjects will be asked to wear a device as part of this study that will collect their biometric data (heart rate, number of steps taken per day, etc) called a WHT device throughout their treatment and for 4 weeks afterward. Subjects will be asked to upload the data from their devices onto the computers in the clinic for the assessment.
Key Dates
- Start date
- May 15, 2026
- Status verified
- Apr 2026
- Primary completion
- Oct 30, 2027
- Completion
- Oct 30, 2027
Study Design
- Enrollment
- 20 participants (estimated)
Arms
- Arm: Biometric Data CollectionAdult subjects with cancer and prescribed concurrent systemic therapy and radiation therapy and enrolled in the study.
Primary Outcome Measure
The rate of technology adoption [ Time Frame: Up to 12 weeks ]
Central Contacts
- Victoria Xu+1 984-974-8744
- Crystal Walker
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Novant Health Cancer Institute Radiation Oncology | Wilmington | North Carolina | 28401 | Lukasz Mazur (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Wilmington, NC
Related Studies
- Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- Pan Tumor Rollover StudyPHASE2 · Recruiting · Bristol-Myers Squibb · Huntsville, Alabama
- Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19Enrolling By Invitation · Duke University · Durham, North Carolina